Literature DB >> 4283280

Inhibition of in vitro lymphocyte blastogenesis by inhibitor produced by cultured human lymphoblasts.

E M Hersh, K B McCredie, E J Freireich.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4283280      PMCID： PMC1554085     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN： 0009-9104            Impact factor:   4.330


× No keyword cloud information.
  16 in total

1.  Specific inhibition of lymphocyte blastogenic responses to mitogens by a factor produced by cultured human malignant lymphoma cells.

Authors:  E M Hersh; B Drewinko
Journal:  Cancer Res       Date:  1974-01       Impact factor: 12.701

2.  Lymphoid inhibitor of human lymphocyte DNA synthesis and mitosis in vitro.

Authors:  J F Moorhead; E Paraskova-Tchernozenska; A J Pirrie; C Hayes
Journal:  Nature       Date:  1969-12-20       Impact factor: 49.962

3.  Influence of cell density on response of leukocytes and column-purified lymphocytes to mitogenic agents.

Authors:  E M Hersh; J E Harris; E A Rogers
Journal:  J Reticuloendothel Soc       Date:  1970-05

4.  Studies of an inhibitor of DNA synthesis and a nonspecific mitogen elaborated by human lymphoblasts.

Authors:  R T Smith; J A Bausher; W H Adler
Journal:  Am J Pathol       Date:  1970-09       Impact factor: 4.307

5.  Products of lymphoid cells in continuous culture.

Authors:  P R Glade; K Hirschhorn
Journal:  Am J Pathol       Date:  1970-09       Impact factor: 4.307

6.  Chloroma regression induced by the granulocytic chalone.

Authors:  T Rytömaa; K Kiviniemi
Journal:  Nature       Date:  1969-06-07       Impact factor: 49.962

7.  "Lymphokines": non-antibody mediators of cellular immunity generated by lymphocyte activation.

Authors:  D C Dumonde; R A Wolstencroft; G S Panayi; M Matthew; J Morley; W T Howson
Journal:  Nature       Date:  1969-10-04       Impact factor: 49.962

8.  The effects of adding reticulo-endothelial tissue extracts to human leucocyte cultures.

Authors:  G D Pegrum; C J Barry
Journal:  J Pathol Bacteriol       Date:  1968-07

9.  Control of cell production in rat chloroleukemia by means of the granulocytic chalone.

Authors:  T Rytöma; K Kiviniemi
Journal:  Nature       Date:  1968-10-12       Impact factor: 49.962

10.  Separation and collection of leukocytes.

Authors:  E J Freireich; G Judson; R H Levin
Journal:  Cancer Res       Date:  1965-10       Impact factor: 12.701
View more
  7 in total

1.  Disparity in the production of lymphoblastogenesis inhibition factor by cultured human B and T lymphoid cell lines.

Authors:  T Han; J L Pauly; J Minowada
Journal:  Clin Exp Immunol       Date:  1975-04       Impact factor: 4.330

2.  Inhibition of the mitogenic response of normal peripheral lymphocytes by extracts or supernatant fluids of a Herpesvirus saimiri lymphoid tumor cell line.

Authors:  R H Neubauer; W C Wallen; H Rabin
Journal:  Infect Immun       Date:  1975-11       Impact factor: 3.441

3.  Further purification and chemical characterization of the lymphocyte-inhibiting-factor extracted from thymus (LIFT).

Authors:  N Kiger; I Florentin; G Lorans; G Mathe
Journal:  Immunology       Date:  1977-10       Impact factor: 7.397

Review 4.  [Humoral factors in the regulation of cell proliferation in haematopoiesis. I. Granulopoiesis and lymphopoiesis (author's transl)].

Authors:  E Heidemann
Journal:  Klin Wochenschr       Date:  1980-10-15

5.  Supernatant derived from a human hepatocellular carcinoma cell line (PLC/PRF/5) activates a population of T-suppressor cells.

Authors:  A Keong; A R Rabson
Journal:  Cancer Immunol Immunother       Date:  1983       Impact factor: 6.968

6.  Blastogenic response of Toxoplasma-infected mouse spleen cells to T- and B-cell mitogens.

Authors:  G T Strickland; A Ahmed; K W Sell
Journal:  Clin Exp Immunol       Date:  1975-10       Impact factor: 4.330

7.  Serum-free culture of hamster lymphoid cells and differential inhibition of lipopolysaccharide stimulation by isologous serum.

Authors:  J S Streilein; D A Hart
Journal:  Infect Immun       Date:  1976-08       Impact factor: 3.441
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.